E-LIB Suche - Ergebnisse für: Nadal, Ernest

1

RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutate..:

Nishino, Kazumi ; Shih, Jin-Yuan ; Nakagawa, Kazuhiko...
JTO Clinical and Research Reports. 5 (2024) 2 - p. 100624 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy and safety of crizotinib in the treatment of advan..:

Nadal, Ernest ; Rifi, Nada ; Kane, Sarah...
Lung Cancer. 192 (2024) - p. 107816 , 2024

Link: https://doi.org/10.1016/..

3

MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Follow..:

Reck, Martin ; Nadal, Ernest ; Girard, Nicolas...
Clinical Lung Cancer. , 2024

Link: https://doi.org/10.1016/..

4

BRAF mutational status is associated with survival outcomes..:

Provencio, Mariano ; Robado de Lope, Lucía ; Serna-Blasco, Roberto...
Lung Cancer. 194 (2024) - p. 107865 , 2024

Link: https://doi.org/10.1016/..

5

Association Between Lung Immune Prognostic Index and Durval..:

Riudavets, Mariona ; Auclin, Edouard ; Mosteiro, Miguel...
Clinical Lung Cancer. 25 (2024) 3 - p. 233-243.e8 , 2024

Link: https://doi.org/10.1016/..

6

RET Fusion Testing in Patients With NSCLC: The RETING Study:

Conde, Esther ; Hernandez, Susana ; Rodriguez Carrillo, Jose Luis...
JTO Clinical and Research Reports. 5 (2024) 4 - p. 100653 , 2024

Link: https://doi.org/10.1016/..

7

A plain language summary of the PHAROS study: the combinati..:

Riely, Gregory J ; Smit, Egbert F ; Ahn, Myung-Ju...
Future Oncology. 20 (2024) 16 - p. 1047-1055 , 2024

Link: https://doi.org/10.2217/..

8

Entrectinib in ROS1-positive advanced non-small cell lung c..:

Peters, Solange ; Gadgeel, Shirish M. ; Mok, Tony...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

9

Urinary soluble PD-1 as a biomarker of Checkpoint Inhibitor..:

Gomez-Preciado, Francisco ; Martinez-Valenzuela, Laura ; Anton-Pampols, Paula...
Clinical Kidney Journal. , 2024

Link: https://doi.org/10.1093/..

10

Multidisciplinary approach for locally advanced non-small c..:

Ospina, Aylen Vanessa ; Bolufer Nadal, Sergio ; Campo-Cañaveral de la Cruz, José Luis...
Clinical and Translational Oncology. 26 (2024) 7 - p. 1647-1663 , 2024

Link: https://doi.org/10.1007/..

11

#3789 SERUM AND URINARY SOLUBLE PD-1, PD-L1 AND PD-L2 AS BI..:

Gomez-Preciado, Francisco ; Valenzuela, Laura Martinez ; Pampols, Paula Anton...
Nephrology Dialysis Transplantation. 38 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

12

European Epidemiology of Pleural Mesothelioma—Real-Life Dat..:

Opitz, Isabelle ; Bille, Andrea ; Dafni, Urania...
Journal of Thoracic Oncology. 18 (2023) 9 - p. 1233-1247 , 2023

Link: https://doi.org/10.1016/..

13

Transcriptional profiling of molecular pathways allows for ..:

Hijazo‐Pechero, Sara ; Alay, Ania ; Cordero, David...
Clinical and Translational Medicine. 13 (2023) 9 - p. , 2023

Link: https://doi.org/10.1002/..

14

Brief report: High incidence of peridiagnosis thromboemboli..:

Aparicio, Inmaculada ; Iranzo, Patricia ; Reyes, Roxana...
Thrombosis Research. 232 (2023) - p. 133-137 , 2023

Link: https://doi.org/10.1016/..

15

Second-line treatment outcomes after progression from first..:

Auclin, Edouard ; Benitez-Montanez, Jose ; Tagliamento, Marco...
Lung Cancer. 178 (2023) - p. 116-122 , 2023

Link: https://doi.org/10.1016/..